124 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... Clopidogrel to Prasugrel ... High Potency: Prasugrel ... Ticagrelor to Prasugrel ... #switching #conversion
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Antiplatelet Conversion ... - P2Y12 Inhibitor ... active site of the P2Y12 ... #Antiplatelet #Conversion ... #P2Y12 #Inhibitor
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching Between Oral P2Y12 ... escalating to prasugrel ... CIRCULATIONAHA.117.031164 #P2Y12 ... Inhibitor #switching #conversion
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
combination with P2Y12 ... anticoagulation in a-fib P2Y12 ... (clopidogrel, prasugrel ... - Inhibits the P2Y12
Oral P2Y12 Inhibitor Pharmacology

 • Clopidogrel
 • Prasugrel
 • Ticagrelor

By Kyle Fischer, PharmD @Kfischer_10

#P2Y12 #Inhibitor #Pharmacology
Oral P2Y12 Inhibitor ... Clopidogrel • Prasugrel ... Kfischer_10 #P2Y12
Loop diuretic PO --> IV conversions 

Furosemide 40 mg PO = Furosemide 20 mg IV =
diuretic PO --> IV conversions ... Equivalent #Dose #Conversion
Common IV to PO Drug Conversions
1) Metoprolol 1:2.5
2) Diltiazem Oral Dose(mg/day) = [ rate (mg/hr) x
IV to PO Drug Conversions ... #IVtoPO #Drug #Conversion
Metoprolol and Carvedilol - Immediate to Extended Release Dose Conversions

Metoprolol 
Immediate (tartrate) -> Extended (succinate) 
25
Extended Release Dose Conversions ... ExtendedRelease #Dose #Conversion
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Recommended Dose Conversions ... at-a-glance dose conversion ... Blockers #ARB #Conversion
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous
Adenosine Diphosphate P2Y12 ... #Clopidogrel #Prasugrel